Adams LA - Search Results

1

Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.

Bertot LC, Jeffrey GP, de Boer B, Wang Z, Huang Y, Garas G, MacQuillan G, Wallace M, Smith BW, Adams LA. Bertot LC, et al. Among authors: adams la. Dig Dis Sci. 2023 Jun;68(6):2757-2767. doi: 10.1007/s10620-023-07896-3. Epub 2023 Mar 22. Dig Dis Sci. 2023. PMID: 36947289 Free PMC article.

2

Ticlopidine-associated cholestatic hepatitis.

Adams L, Jeffrey GP, Deboer B, Garas G. Adams L, et al. Intern Med J. 2002 Jul;32(7):359-60. doi: 10.1046/j.1445-5994.2002.00241.x. Intern Med J. 2002. PMID: 12088359 No abstract available.

3

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.

Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G. Rossi E, et al. Clin Chem. 2003 Mar;49(3):450-4. doi: 10.1373/49.3.450. Clin Chem. 2003. PMID: 12600957

4

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Adams LA, et al. Clin Chem. 2005 Oct;51(10):1867-73. doi: 10.1373/clinchem.2005.048389. Epub 2005 Jul 28. Clin Chem. 2005. PMID: 16055434

5

Ganciclovir and the treatment of Epstein-Barr virus hepatitis.

Adams LA, Deboer B, Jeffrey G, Marley R, Garas G. Adams LA, et al. J Gastroenterol Hepatol. 2006 Nov;21(11):1758-60. doi: 10.1111/j.1440-1746.2006.03257.x. J Gastroenterol Hepatol. 2006. PMID: 16984606

6

Assessing liver fibrosis with serum marker models.

Rossi E, Adams LA, Bulsara M, Jeffrey GP. Rossi E, et al. Among authors: adams la. Clin Biochem Rev. 2007 Feb;28(1):3-10. Clin Biochem Rev. 2007. PMID: 17603636 Free PMC article.

7

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Mitchell A, Adams LA, MacQuillan G, Tibballs J, vanden Driesen R, Delriviere L. Mitchell A, et al. Among authors: adams la. Liver Transpl. 2008 Feb;14(2):210-3. doi: 10.1002/lt.21417. Liver Transpl. 2008. PMID: 18236396 Free article.

8

Levetiracetam as a possible cause of fulminant liver failure.

Tan TC, de Boer BW, Mitchell A, Delriviere L, Adams LA, Jeffrey GP, Macquillan G. Tan TC, et al. Among authors: adams la. Neurology. 2008 Aug 26;71(9):685-6. doi: 10.1212/01.wnl.0000324604.11657.c6. Neurology. 2008. PMID: 18725594 No abstract available.

9

Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.

Thin L, Macquillan G, Adams L, Garas G, Seow C, Cannell P, Augustson B, Mitchell A, Delriveire L, Jeffrey G. Thin L, et al. Liver Transpl. 2009 Apr;15(4):421-6. doi: 10.1002/lt.21704. Liver Transpl. 2009. PMID: 19326415 Free article.

10

Hepatic epithelioid haemangioendothelioma: challenges in diagnosis and management.

Thin LW, Wong DD, De Boer BW, Ferguson JM, Adams L, Macquillan G, Delriviere L, Mitchell A, Jeffrey GP. Thin LW, et al. Intern Med J. 2010 Oct;40(10):710-5. doi: 10.1111/j.1445-5994.2009.02043.x. Intern Med J. 2010. PMID: 19712200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters